Clinical application of the concept of relative potency: an example involving chlorpromazine and haloperidol.
Preskorn
Sheldon H
SH
Department of Psychiatry, University of Kansas School of Medicine, Wichita, USA.
D000328:Adult; D014150:Antipsychotic Agents / Q000008:administration & dosage* / Q000009:adverse effects / Q000493:pharmacokinetics / Q000633:toxicity; D002746:Chlorpromazine / Q000008:administration & dosage* / Q000009:adverse effects / Q000493:pharmacokinetics / Q000633:toxicity; D004305:Dose-Response Relationship, Drug; D004637:Emergency Services, Psychiatric; D006220:Haloperidol / Q000008:administration & dosage* / Q000009:adverse effects / Q000493:pharmacokinetics / Q000633:toxicity; D006801:Humans; D007273:Injections, Intramuscular; D007396:Internship and Residency; D008297:Male; D008508:Medication Errors; D010343:Patient Admission; D011570:Psychiatry / Q000193:education; D011618:Psychotic Disorders / Q000175:diagnosis / Q000188:drug therapy* / Q000523:psychology; D012307:Risk Factors
D014150:Antipsychotic Agents; D006220:Haloperidol; D002746:Chlorpromazine